Increased interleukin-8 concentrations in the pulmonary edema fluid of patients with acute respiratory distress syndrome from sepsis

Critical Care Medicine

Volumn 24, Issue 9, 1996, Pages 1448-1454

  Miller, Edmund J ^a   Cohen, Allen B ^a,b   Matthay, Michael A ^c  

^a UNIVERSITY OF TEXAS AT TYLER   (United States)

^b The University of Texas Health Science Center at Tyler   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

acute lung injury; ARDS; critical illness; cytokines; interleukin 8; lungs; pulmonary edema; pulmonary emergencies; sepsis

Indexed keywords

INTERLEUKIN 8;

ADULT; AGED; ARTICLE; BODY FLUID; CLINICAL ARTICLE; FEMALE; HEART FAILURE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; IMMUNOSTIMULATION; LUNG EDEMA; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN CONTENT; RESPIRATORY DISTRESS SYNDROME; SEPSIS;

EID: 0029832280     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199609000-00004     Document Type: Article

References (49)

1. Baggiolini M, Walz A, Kunkel SL: Neutrophil-activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils. J Clin Invest 1989; 84: 1045-1049
2. Matsushima K, Oppenheim J: Interleukin-8 and MCAF: Novel inflammatory cytokines inducible by IL-1 and TNF. Cytokine 1989; 1:2-13
3. Strieter RM, Chensue SW, Basha MA, et al: Human alveolar macrophage gene expression of interleukin-8 by tumor necrosis factor-alpha, lipopolysaccharide, and interleukin-1 beta. Am J Respir Cell Mol Biol 1990; 2:321-326
4. Boylan AM, Rüegg C, Kim KJ, et al: Evidence of a role for mesothelial cell-derived interleukin 8 in the pathogenesis of asbestos-induced pleurisy in rabbits. J Clin Invest 1992; 89:1257-1267
5. Van Damme J, Decock B, Conin R, et al: The chemotactic activity of granulocytes produced by virally infected fibroblasts is identical to monocyte-derived interleukin 8. Eur J Immunol 1989; 19: 1189-1194
6. Standiford TJ, Kunkel SL, Basha MA, et al: Interleukin-8 gene expression by a pulmonary epithelial cell line; a model for cytokine networks in the lung. J Clin Invest 1990; 86:1945-1953
7. Strieter RM, Phan SH, Schowell HJ, et al: Monokine-induced neutrophil chemotactic factor gene expression in human fibroblasts. J Biol Chem 1989; 264: 10621-10626
8. Strieter RM, Kunkel SL, Showell HJ, et al: Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1 beta. Science 1989; 243:1467-1469
9. Strieter RM, Kasahara K, Allen RM, et al: Cytokine-induced neutrophil-derived interleukin-8. Am J Pathol 1992; 141:397-407
10. Griffith DE, Miller EJ, Gray LD, et al: Interleukin-1 mediated release of interleukin-8 by asbestos-stimulated mesothelial cells. Am J Respir Cell Mol Biol 1994; 10:245-253
11. Terkeltaub R, Azchariae C, Santoro D, et al: Monocyte-derived neutrophil chemotactic factor/interleukin-8 is a potential mediator of crystal-induced inflammation. Arthritis Rheum 1991; 34: 894-903
12. Mulligan MS, Jones ML, Bolanowski MA, et al: Inhibition of lung inflammatory reactions in rats by an anti-human IL-8 antibody. J Immunol 1993; 150: 5585-5595
13. Sekido N, Mukaida N, Harada A, et al: Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature 1993; 365:654-657
14. Folkesson HG, Matthay MA, Hebert CA, et al: Acid aspiration induced lung injury is mediated by interleukin-8 dependent mechanisms. J Clin Invest 1995; 96:107-116
15. Miller EJ, Cohen AB, Nagao S, et al: Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis 1992; 146:427-432
16. Chollet-Martin S, Montravers P, Gilbert C, et al: High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome. Infect Immun 1993: 51:4553-4559
17. Donnelly TJ, Meade P, Jagels M, et al: Cytokine, complement, and endotoxin profiles associated with the development of the adult respiratory distress syndrome after severe injury. Crit Care Med 1994; 22:768-776
18. Donnelly SC, Strieter RM, Kunkel SL, et al: Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 1993; 341: 643-647
19. Tate RM, Repine JE: Neutrophils and the adult respiratory distress syndrome. Am Rev Respir Dis 1991; 144:251-252
20. Wortel CH, Doerschuk CM: Neutrophils and neutrophil-endothelial cell adhesion in adult respiratory distress syndrome. New Horiz 1993; 1:631-637
21. Maunder RJ, Hackman RC, Riff E, et al: Occurrence of the adult respiratory distress syndrome in neutropenic patients. Am Rev Respir Dis 1986; 133:313-316
22. Fein A, Lippmann M, Holtzman H: The risk factors, incidence, and prognosis of ARDS following septicemia. Chest 1983; 40:84-86
23. Montgomery AB, Stager MA, Carrico CJ, et al: Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1985; 132:485-489
24. Doyle R, Szflarski N, Modin G, et al: Identification of patients with acute lung injury: Predictors of mortality. Am J Respir Crit Care Med 1995; 152: 1818-1824
25. Miller EJ, Nagao S, Carr FK, et al: Interleukin-8 is a major neutrophil chemotaxin from alveolar macrophages stimulated with staphylococcal enterotoxin. Inflamm Res, In Press
26. Friedland JS, Suputtamongkol Y, Remick DG, et al: Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized Pseudomonas pseudomallei infection. Infect Immun 1992; 60:2402-2408
27. Massion PP, Inoue H, Richman-Eisenstat J, et al: Novel Pseudomonas product stimulates interleukin-8 production in airway epithelial cells in vitro. J Clin Invest 1994; 93:26-32
28. Betjes MG, Tuk CW, Struik DG, et al: Interleukin-8 production by human peritoneal mesothelial cells in response to tumor necrosis factor-alpha, interleukin-1, and medium conditioned by macrophages cocultured with Staphylococcus epidermidis. J Infect Dis 1993; 168: 1202-1210
29. Christman JW, Holden EP, Blackwell TS: Strategies for blocking the systemic effects of cytokines in the sepsis syndrome. Crit Care Med 1995; 23: 955-963
30. Bernard GR, Artigas A, Brigham KL, et al: The North American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149:818-824
31. Rubin DB, Wiener-Kronish JP, Murray JF, et al: Elevated von Willebrand factor antigen is an early plasma marker of impending acute lung injury and death in non-pulmonary sepsis syndrome. J Clin Invest 1990; 86:474-480
32. Aberle DR, Wiener-Kronish JP, Webb RW, et al: Hydrostatic versus increased permeability pulmonary edema: Diagnosis based on radiographic criteria in critically ill patients. Radiology 1988; 168:73-79
33. Matthay MA, Wiener-Kronish JP: Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. Am Rev Respir Dis 1990; 142:1250-1257
34. Milberg JA, Davis DR, Steiberg KP, et al: Improved survival of patients with acute respiratory distress syndrome (ARDS). JAMA 1995; 273:306-309
35. Windsor CJ, Walsh CJ, Mullen PG, et al: Tumor necrosis factor-α blockade prevents neutrophil CD18 receptor upregulation and attenuates acute lung injury in porcine sepsis without inhibition of neutrophil oxygen radical metabolism. J Clin Invest 1993; 91: 1459-1468
36. Redl H, Schlag, G, Bahrami S, et al: Plasma neutrophil-activating peptide-1/ interleukin-8 and neutrophil elastase in a primate bacteremia model. J Infect Dis 1991; 164:383-388
37. Seitz M, DeWald B, Gerber N, et al: Enhanced production of interleukin-8 in rheumatoid arthritis. J Clin Invest 1991; 87:463-469
38. Miller EJ, Idell S: Interleukin-8: An important neutrophil chemotaxin in some cases of exudative pleural effusions. Exp Lung Res 1993; 19:589-601
39. Southcott AM, Jones KP, Li D, et al: Interleukin-8: Differential expression in lone fibrosing alveolitis and systemic sclerosis. Am J Respir Crit Care Med 1995; 151:1604-1612
40. Miller EJ, Kurdowska A, Nagao S, et al: A synthetic peptide which specifically inhibits heat treated interleukin-8 binding and chemotaxis for neutrophils. Agents Actions 1993; 40:200-208
41. Hack CE, Hart M, Strack van Schijndel RJM, et al: Interleukin-8 in sepsis: Relation to shock and inflammatory mediators. Infect Immun 1992; 60:2835-2842
42. Darbonne WC, Rice GC, Mohler MA, et al: Red blood cells are a sink for interleukin-8, a leukocyte chemotaxin. J Clin Invest 1991; 88:1362-1369
43. Matthay MA, Sadik M, Reichert M, et al: Red blood cells function as a major clearance for chemokines (IL-8, MGSA, RANTES) in critically ill patients. Abstr. Am J Respir Crit Care Med 1995; 151: A318
44. Murray JF, Matthay MA, Luce JM, et al: An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988; 138:720-723
45. Hyers TM, Fowler AA: Adult respiratory distress syndrome: Causes, morbidity and mortality. Fed Proc 1986; 45: 25-29
46. Schnapp LM, Chin DP, Szaflarski N, et al: Frequency and importance of barotrauma in 100 patients with acute lung injury. Crit Care Med 1995; 23: 272-278
47. Kurdowska A, Miller EJ, Cohen AB: An anti-interleukin-8 monoclonal antibody which interferes with the binding of interleukin-8 to cellular receptors and the activation of human blood neutrophils. Hybridoma 1995; 14:225-233
48. Hayashi S, Kurdowska A, Miller EJ, et al: Synthetic hexa and heptapeptides that inhibit IL-8 for binding to and activating human blood neutrophils. J Immunol 1995; 154:814-824
49. Green LL, Hardy MC, Maynard-Currie CE, et al: Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs. Nat Genet 1994; 7:13-21